Assessment of the Phototoxic Potential of LEO 29102 Cream

Inclusion Criteria: * Subjects having understood and signed an informed consent form * Male adults between the age of 18 and 65 years (both inclusive) * Healthy subjects without signs of skin irritation on test areas (erythema, dryness, roughness or scaling) * Subjects willing and able to follow all the study procedures and complete the whole study * Subjects affiliated to a social security system Exclusion Criteria: * Females * Males who are not willing to use a local contraception for the entire duration of the study, and refrain from fathering a child within 3 months following the study drug * Systemic treatments which may interfere with the inflammatory reaction (e.g., corticosteroids and other anti-inflammatory drugs) within 2 weeks prior to randomisation * Systemic or topical treatments suspected of causing photobiological reactions (e.g., tetracycline, thiazides, fluoroquinolones) within 4 weeks prior to randomisation * Exposure to excessive or chronic UV radiation (i.e., sunbathing, solarium, phototherapy) within 4 weeks prior to inclusion or is planned during the study period * Dark pigmentation of the skin or skin type that may, in any way, confound interpretation of the study results (skin types V and VI on the Fitzpatrick scale) * Scars, moles, sunburn or other blemishes in the test area which may interfere with grading * Any systemic or cutaneous disease on the test area that may confound interpretation of the study results (e.g., atopic dermatitis, eczema, ps…